Author

Jonas Franz

Boston UniversityPrimary ORCID profile (0000-0001-7523-6622 · 4 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jonas FranziD4 papers · Universitätsmedizin Göttingen

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

M. Elizabeth FiniiD· 1 shared Mark R. WilsoniD· 1 shared Sharmila MasliiD· 1 shared Shivali GuptaiD· 1 shared Tat Fong NgiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 10 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

M. Elizabeth FiniORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Clusterin reverses epitheliopathy, reduces inflammation, and restores goblet cells and corneal nerves in a mouse model of autoimmune dry eye

Jonas Franz, Tat Fong Ng, Shivali Gupta, Mark R. Wilson, M. Elizabeth Fini, Sharmila Masli

This study tests clusterin's therapeutic effects in a mouse model of autoimmune dry eye, finding it improves corneal barrier function, nerve density, and goblet cell regeneration while reducing inflammation, comparable to dexamethasone.

Scientific Reports · Feb 15, 2026Peer-reviewedImmunology